Impact of prior COVID-19 vaccination on major adverse kidney events in patients with non-dialysis dependent chronic kidney disease: a global retrospective study
In CKD patients with COVID-19, prior vaccination significantly reduced risks of MAKEs and mortality, especially with three or more doses. These findings underscore the clinical importance of adhering to recommended vaccination schedules to improve kidney outcomes and survival in this vulnerable population.
Authors
- Chi-Ya Huang
- Man‐Hsin Hung (ORCID: https://orcid.org/0000-0002-7449-5857)
- Guan-Yu Lin (ORCID: https://orcid.org/0000-0003-3772-4515)
- Tsung Yu (ORCID: https://orcid.org/0000-0002-5773-3665)
- I‐Ning Yang
- Jheng‐Yan Wu (ORCID: https://orcid.org/0000-0002-3290-1909)
- Sisi He (ORCID: https://orcid.org/0000-0003-0769-9590)
- Ming-Cheng Wang (ORCID: https://orcid.org/0000-0003-1668-9319)
- Hsien-Yi Wang
Institutions
- Chung Hwa University of Medical Technology (TW)
- National Sun Yat-sen University (TW)
- Chi Mei Medical Center (TW)
- National Cheng Kung University Hospital (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- Expert Review of Vaccines
- Published
- 2025-07-20
- DOI
- https://doi.org/10.1080/14760584.2025.2536077
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00